A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent | PLOS ONE
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP - ScienceDirect
Table 2 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Outcome according to the revised International Prognostic Index (R-IPI)... | Download Scientific Diagram
Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era | BMC Cancer
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
PPT - DLBCL PowerPoint Presentation, free download - ID:4727334
Response to treatment according to different R-IPI categories | Download Table
Extracting Randomness from the Trend of IPI for Cryptographic Operations in Implantable Medical Devices – RISS
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download
Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to Management?
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
A prognostic index predicting survival in transformed Waldenström macroglobulinemia | Haematologica
Improving Outcomes and Evaluating Novel Treatment Approaches for Patients With DLBCL or MCL (Transcript)
Progression free survival (A) and overall survival (B) stratified by... | Download Scientific Diagram
DLBCL- Recent Molecular Classification.pptx
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation | Bone Marrow Transplantation
Table 2 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurately Predict Survival Risk And Improve Treatment Decisions
![Distribution of patients inside risk groups and OS by standard IPI [8],... | Download Table](https://www.researchgate.net/profile/Santo-Neri/publication/38095873/figure/tbl1/AS:667607128604690@1536181351880/Distribution-of-patients-inside-risk-groups-and-OS-by-standard-IPI-8-R-IPI-3-and_Q320.jpg "Distribution of patients inside risk groups and OS by standard IPI [8],... | Download Table")
Distribution of patients inside risk groups and OS by standard IPI [8],... | Download Table
